SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-10-112950
Filing Date
2010-05-07
Accepted
2010-05-07 16:31:22
Documents
11
Period of Report
2010-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 647390
2 FORM OF STOCK OPTION AGREEMENT AND RESTRICTED STOCK UNIT AGREEMENT dex102.htm EX-10.2 248963
3 FORM OF PERFORMANCE UNIT AGREEMENT dex104.htm EX-10.4 109931
4 SECTION 302 CERTIFICATIONS dex31.htm EX-31 21148
5 SECTION 906 CERTIFICATIONS dex32.htm EX-32 8865
  Complete submission text file 0001193125-10-112950.txt   2548110

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT amgn-20100331.xml EX-101.INS 350115
7 XBRL TAXONOMY EXTENSION SCHEMA amgn-20100331.xsd EX-101.SCH 11330
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE amgn-20100331_cal.xml EX-101.CAL 34764
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE amgn-20100331_def.xml EX-101.DEF 72671
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE amgn-20100331_lab.xml EX-101.LAB 77440
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amgn-20100331_pre.xml EX-101.PRE 88188
Mailing Address ONE AMGEN CENTER DRIVE MAIL STOP 24-1-B THOUSAND OAKS CA 91320-1799
Business Address ONE AMGEN CENTER DRIVE MAIL STOP 24-1-B THOUSAND OAKS CA 91320-1799 (805)313-1762
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-12477 | Film No.: 10812850
SIC: 2836 Biological Products, (No Diagnostic Substances)